Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-authorization safety study of interferon beta-1a in relapsing multiple sclerosis
2006-000606-23Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2012
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of interferon beta-1a in multiple sclerosis (MS), sponsored by Merck & Co. Started Mar 2012; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2006-000606-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000606-23.